Bloomberg Businessweek

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

OpenAI is preparing to file for an initial public offering in the coming weeks and is targeting a public debut sometime in the fall, according to a person familiar with the plan.

The ChatGPT creator is working with Goldman Sachs and Morgan Stanley to make a confidential IPO filing as soon as Friday, but the exact timing remains uncertain, the person said, asking not to be identified because the information isn’t public. OpenAI said in a statement: “We regularly evaluate a range of strategic options. Our focus remains on execution.”

OpenAI has been laying the groundwork to go public as soon as this year as part of a broader effort to raise more capital and pay for its costly push for more chips, data centers and talent, Bloomberg News has previously reported. Rivals Anthropic PBC and SpaceX are also preparing for listings. SpaceX’s IPO paperwork may be made public as soon as Wednesday.

On this episode, Carol and Tim speak with:
Ed Ludlow, Bloomberg Tech Co-Host
Kurt Wagner, Bloomberg News Senior Technology Reporter on Meta Begins 8,000 Global Job Cuts in AI Efficiency Push
Patrick Clark, Bloomberg News Real Estate Reporter on Wall Street Takes Its Cut of $34 Trillion in US Homeowner Wealth
See omnystudio.com/listener for privacy information.

The Golden State Valkyries have made sports history by becoming the first $1 billion franchise in women's sports. In just its second year in the league, that makes the Valkyries the first-ever women’s team in any sport to reach that valuation. Jess Smith is President of the WNBA team Golden State Valkyries. She speaks with Tim Stenovec and Alexandra Semenova.
See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Today, the debate is no longer about authenticity. It is about value perception, branding, sustainability, craftsmanship, transparency and consumer preference. Lab-grown diamonds are now widely accepted as real diamonds, with the same physical, chemical and optical properties as mined diamonds. The FTC and international trade standards recognize laboratory-grown diamonds as diamonds, provided disclosure is clear. Consumer perception has shifted dramatically over the last few years, moving the discussion away from origin and towards quality, craftsmanship, light performance and value. Lab-grown diamonds should not be confused with simulants such as cubic zirconia or moissanite, which are not carbon-based diamonds.

On this episode, Carol and Tim speak with:
Nathalie Morrison, Astrea London Founder
Brett Mufson, President of Fontainebleau Development
Kristy Ellmer, BCG US Managing Partner & Director AND co-author of 'How Change Really Works'
See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec broadcast live from the NYSE trading floor with our partners at LifeMD for important conversations on the future of the healthcare industry.
On this episode, Carol and Tim speak with:
Dr. Joan LaRovere, Interim CMO Boston Children's Hospital AND Co-Founder & President of the Virtue Foundation
Dr. Stephanie Faubion, Medical Director of The Menopause Society AND Penny and Bill George Director of Mayo Clinic's Center for Women's Health
Dr. Karen Koffler, Director, Integrative and Functional Medicine, Miami Whole Health; Professor, University of Miami School of Medicine
See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Carol Massar and Tim Stenovec broadcast live from the NYSE trading floor with our partners at LifeMD for important conversations on the future of the healthcare industry.
On this episode, Carol and Tim speak with:
Dr. Doug Lucas, Orthopedic Surgeon; Clinical Lead, Bone Health & Longevity, LifeMD
Rear Admiral Dr. Susan Blumenthal, Former Assistant Surgeon General and the First-ever Deputy Assistant Secretary for Women’s Health
Justin Schreiber, LifeMD Chairman CEO & Co-Founder
See omnystudio.com/listener for privacy information.